Hyercalcemia induced by interferon therapy in chronic hepatitis C
- PMID: 22870420
- PMCID: PMC3410179
- DOI: 10.4103/2230-8229.98308
Hyercalcemia induced by interferon therapy in chronic hepatitis C
Abstract
Interferon is being increasingly used in the treatment of chronic hepatitis C. Several case reports have suggested an association between interferon therapy and sarcoidosis with hypercalcemia. We report a case of severe hypercalcemic crisis with bilateral hilar lymphadenopathy in a male patient who was receiving interferon therapy for hepatitis C. Gastroenterologists should be aware of this unusual but clinically important complication of interferon therapy.
Keywords: Hypercalcemia; interferon; sarcoidosis.
Conflict of interest statement
References
-
- Statement on sarcoidosis. Joint Statement (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–55. - PubMed
-
- Ramos–Casals M, Mana J, Nardi N. Sarcoidosis in patients with chronic Hepatitis C Virus Infection: Analysis of 68 cases. Medicine (Baltimore) 2005;84:69–80. - PubMed
-
- Baughman RP. Sarcoidosis, usual and unusual manifestation. Chest. 1988;94:165–70. - PubMed
-
- Judson MA, Baughman RP, Teirstein AS. Defining organ involvement in sarcoidosis.A Case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:75–86. - PubMed